ISIS-GCGRRx

· Ionis Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ISIS-GCGRRx, covering 2016-07-04 to 2018-06-25. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes [Phase 2]